These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6103946)

  • 1. Effects of 3',4'-dihydroxynomifensine on the dopamine vascular receptor.
    Kohli JD; Goldberg LI
    J Pharm Pharmacol; 1980 Mar; 32(3):225-6. PubMed ID: 6103946
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
    Hahn RA; Wardell JR
    J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
    Kohli JD; Weder AB; Goldberg LI; Ginos JZ
    J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopaminergic involvement in the hyperalgesic effect of nomifensine.
    Gonzalez JP; Sewell RD; Spencer PS
    Life Sci; 1981 Feb; 28(8):951-6. PubMed ID: 7219061
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dopamine on intestinal vessels in anesthetized dogs.
    van Kesteren RG; van Alphen MM; Charbon GA
    Circ Shock; 1988 May; 25(1):41-51. PubMed ID: 3402051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenoxybenzamine and renal blood flow during extracorporeal circulation.
    Mandelbaum I; Silbert M; Berry J
    Surg Forum; 1965; 16():40-2. PubMed ID: 5835211
    [No Abstract]   [Full Text] [Related]  

  • 10. Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine.
    Algeri S; Brunello N; Vantini G
    Pharmacol Res Commun; 1980 Jul; 12(7):675-81. PubMed ID: 6105682
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical effects of nomifensine on catecholaminergic systems: in vivo studies.
    Algeri S; Ponzio F; Achilli G; Perego C
    Adv Biochem Psychopharmacol; 1982; 31():219-28. PubMed ID: 7080897
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for central selective dopamine receptor stimulation in the mediation of nomifensine-induced hyperalgesia and the effects of opiate antagonists.
    Gonzalez JP; Sewell RD; Spencer PS
    Neuropharmacology; 1981 Nov; 20(11):1039-45. PubMed ID: 6275288
    [No Abstract]   [Full Text] [Related]  

  • 13. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere.
    Goldberg LI; Volkman PH; Kohli JD; Kotake AN
    Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine.
    Dandridge PA; Kaiser C; Brenner M; Gaitanopoulos D; Davis LD; Webb RL; Foley JJ; Sarau HM
    J Med Chem; 1984 Jan; 27(1):28-35. PubMed ID: 6317860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nomifensine and body temperature of the rat: interaction with reserpine, chlorpromazine and amphetamine].
    Puche E; Mundo A; García Morillas M; Baeyens JM; Bolaños J
    Arch Farmacol Toxicol; 1979 Aug; 5(2):123-32. PubMed ID: 533317
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the dopamine agonist properties of 8-amino-2-methyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline, a derivative of nomifensine.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1978 Aug; 30(8):514-6. PubMed ID: 28403
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of certain vascular responses to dopamine by morphine.
    Dressler WE; D'Alonzo G; Rossi GV; Orzechowski RF
    Eur J Pharmacol; 1974 Sep; 28(1):108-13. PubMed ID: 4430315
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological characterization of renal vascular dopamine receptors.
    Schmidt M; Imbs JL
    J Cardiovasc Pharmacol; 1980; 2(5):595-605. PubMed ID: 6157952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular dopamine receptor as a model for other dopamine receptors.
    Goldberg LI
    Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of phenoxybenzamine and dopamine in segmental ischaemia of the rat small intestine.
    Gustafsson G; Norlén K; Rentzhog L; Wikström S
    Acta Chir Scand; 1984; 150(2):159-63. PubMed ID: 6720224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.